SBH
CEMI

Segall Bryant & Hamill’s Chembio diagnostics, Inc. CEMI Stock Holding History

Segall Bryant & Hamill’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-350,659
Closed -$877K – 796
2021
Q3 		$877K Sell
350,659
-352,589
-50% -$978K 0.01% 550
2021
Q2 		$2.09M Sell
703,248
-578
-0.1% -$2.02K 0.02% 452
2021
Q1 		$2.48M Sell
703,826
-1,997
-0.3% -$11.1K 0.02% 446
2020
Q4 		$3.35M Buy
705,823
+77,874
+12% +$402K 0.04% 356
2020
Q3 		$3.05M Buy
627,949
+244,039
+64% +$1.16M 0.04% 333
2020
Q2 		$1.25M Sell
383,910
-229,529
-37% -$2.18M 0.02% 398
2020
Q1 		$3.14M Buy
613,439
+21,360
+4% +$86.4K 0.06% 266
2019
Q4 		$2.7M Buy
592,079
+38,309
+7% +$187K 0.04% 347
2019
Q3 		$3.39M Buy
553,770
+92,814
+20% +$553K 0.05% 325
2019
Q2 		$2.81M Buy
460,956
+21,178
+5% +$143K 0.04% 350
2019
Q1 		$2.44M Buy
439,778
+91,151
+26% +$592K 0.04% 377
2018
Q4 		$1.97M Buy
+348,627
New +$2.57M 0.03% 403

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Segall Bryant & Hamill's CEMI Position: Q4 2021 in Review

Segall Bryant & Hamill sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2021, closing a stake of 350,659 shares — an estimated $877K sold.

Segall Bryant & Hamill first reported a position in CEMI in Q4 2018 and held it in 12 quarters. The position peaked at $3.39M in Q3 2019. 43 funds tracked by Wall St. Rank hold CEMI as of Q4 2021.

  • Segall Bryant & Hamill reported no remaining Chembio diagnostics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Segall Bryant & Hamill sold 350,659 Chembio diagnostics, Inc. shares in Q4 2021, an estimated $877K.
  • Segall Bryant & Hamill first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 12 quarters.
  • Segall Bryant & Hamill's Chembio diagnostics, Inc. position peaked at $3.39M in Q3 2019.
  • 43 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2021.

Based on Segall Bryant & Hamill's 13F filing for Q4 2021, filed 14 Feb 2022.